Search details
1.
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer.
Future Oncol
; 19(14): 961-973, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37306090
2.
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study.
Lancet Respir Med
; 11(4): 354-366, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36535300
Results
1 -
2
de 2
1
Next >
>>